Journal Article

FZJ-2022-03305

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas

Werner, J.-M. ; Wolf, L. ; Tscherpel, C. ; Bauer, E. K. ; Wollring, M.FZJ* ; Ceccon, G. ; Deckert, M. ; Brunn, A. ; Pappesch, R. ; Goldbrunner, R. ; Fink, G. R.FZJ* ; Galldiks, N. (Corresponding author)FZJ*

2022
Springer Science + Business Media B.V Dordrecht [u.a.]

This record in other databases:      

Please use a persistent id in citations: http://hdl.handle.net/2128/31832  doi:10.1007/s11060-022-04066-9

---

Contributing Institute(s):

1. Kognitive Neurowissenschaften (INM-3)

Research Program(s):

1. 5252 - Brain Dysfunction and Plasticity (POF4-525) (POF4-525)

Appears in the scientific report 2022

---

Database coverage:
; ; ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Springer ; Essential Science Indicators ; IF < 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---